searchers found that acute wound healing was significantly delayed in the mice lacking Fibulin-2. After 72 hours, they found that the damaged (infarct) area was much larger in the mice lacking Fibulin-2.
The researchers found that the wound healing process was much slower in the mice lacking Fibulin-2 after a heart attack due to delayed scar tissue formation in the damaged area. The study demonstrated that Fibulin-2 facilitates heart wound healing probably with the help of (TGF)-?, a growth factor that promotes wound healing.
The researchers are also currently looking into the role of Fibulin-2 as a factor in the development of chronic heart failure.
Members of the team who conducted this study at Thomas Jefferson University in Philadelphia, Pa., and Alfred I DuPont Hospital for Children in Wilmington, Del., are:
Takeshi Tsuda, M.D.;
Erhe Gao, M.D., Ph.D.;
Francois X. Sicot, Ph.D.;
Hailong Dong, M.D., Ph.D.;
Dessislava Markova, Ph.D.,
Xinliang Ma, M.D., Ph.D. and
Mon-Li Chu, Ph.D.
Contact: Nan Myers
Thomas Jefferson University 27-Mar-2007Page: 1 2 3 4 Related medicine news :1
. Treatment for early prostate cancer associated with type of specialist seen2
. Treatment outcomes of patients with HIV and tuberculosis3
. Treatment of kidney condition requires an individualized approach4
. Treatment for homeless youth pays off in long run, study finds5
. Treatment discovered for deadly childhood disease6
. Treatment developed for patients with medically unexplained symptoms7
. Treatment drug may cause jawbone to die8
. Treatment for anorexia nervosa appears to have improved outcome9
. Treatment reduces gastric ulcers in at-risk patients using long-term NSAIDS10
. North Central Cancer Treatment Group finding ways to make treatment easier11
. Treatment of severe coronary artery disease with drug-eluting stents a viable alternative to CABG